Prescribing Patterns in Fatal Intoxications Involving Zopiclone and Alprazolam: An Observational Register‐Based Study
Basic & Clinical Pharmacology & Toxicology · 2026-07 · 139 (1)
DOI: 10.1111/bcpt.70256 ↗At a glance
Beobachtungsstudie in Basic & Clinical Pharmacology & Toxicology, published online on 2026-06-03. Written by Lova Tralla and 4 co-authors. Institution: Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Major MEDLINE topics: Alprazolam, Azabicyclo Compounds, Hypnotics and Sedatives, Piperazines. 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: Linköping University, National Board of Forensic Medicine in Sweden, Linköpings Universitet.
Abstract (original language)
Background
Zopiclone was recently identified as a frequent contributor to fatal drug‐intoxications in Sweden. However, characteristics of misuse and factors associated with prescribed use remain insufficiently described. Alprazolam has a more established misuse profile.
Objective
The aim of the study was to describe and compare characteristics of fatal intoxications positive for zopiclone or alprazolam, focusing on prescription status and factors associated with prescribed drug use.
Methods
Fatal intoxications between 2012 and 2020 with zopiclone and/or alprazolam in blood were identified using the Swedish Cause of Death Register and the Swedish forensic medicine database. Prescriptions within 1 year before death, and health and sociodemographic data were obtained from national registers.
Results
Among 1270 zopiclone cases, 84% were prescribed users compared to 22% of 1532 alprazolam cases. For both substances, prescribed use was associated with female sex (zopiclone: aOR = 1.68, 95% CI = 1.22–2.30; alprazolam: aOR = 2.04, 95% CI = 1.54–2.71), suicide relative to accidental intoxication (zopiclone: aOR = 1.61, 95% CI = 1.11–2.33; alprazolam: aOR = 3.21, 95% CI = 2.16–4.75) and age ≥ 46 years (zopiclone: aOR = 2.26, 95% CI = 1.45–3.54; alprazolam: aOR = 3.20, 95% CI = 2.29–4.46). Psychiatry‐contact and previous self‐harm were associated with prescribed zopiclone use, but not alprazolam.
Conclusion
Fatal intoxications involving zopiclone differ from alprazolam. While factors associated with prescribed use were often shared, substance‐specific preventative strategies could be beneficial.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden.
ORCID profiles: Lova Tralla, Fredrik C Kugelberg
Funding
- Linköping University
- National Board of Forensic Medicine in Sweden
- Linköpings Universitet
Cite
APA
Tralla, L., Gustavsson, S., Söderberg, C., Jönsson, A. K., & Kugelberg, F. C. (2026). Prescribing Patterns in Fatal Intoxications Involving Zopiclone and Alprazolam: An Observational Register‐Based Study. Basic & Clinical Pharmacology & Toxicology, 139(1). https://doi.org/10.1111/bcpt.70256
Vancouver
Tralla L, Gustavsson S, Söderberg C, Jönsson AK, Kugelberg FC. Prescribing Patterns in Fatal Intoxications Involving Zopiclone and Alprazolam: An Observational Register‐Based Study. Basic & Clinical Pharmacology & Toxicology. 2026;139(1). doi:10.1111/bcpt.70256
BibTeX
@article{Tralla2026,
author = {Tralla, Lova and Gustavsson, Sara and Söderberg, Carl and Jönsson, Anna K and Kugelberg, Fredrik C},
title = {Prescribing Patterns in Fatal Intoxications Involving Zopiclone and Alprazolam: An Observational Register‐Based Study},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {139},
number = {1},
doi = {10.1111/bcpt.70256}
}
EUVIMED